These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 38386164)

  • 21. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM; Keating GM
    Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction Versus Maintenance Immunosuppression After Intestinal Transplant: Determining Which Treatment Most Impacts Long-Term Patient And Graft Survival.
    Gentilini MV; Perez-Illidge L; Pedraza N; Nemirovsky SI; Fernandez MF; Ramisch D; Solar H; Rumbo M; Rumbo C; Gondolesi GE
    Exp Clin Transplant; 2022 Dec; 20(12):1105-1113. PubMed ID: 36718010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.
    Marcén R
    Drugs; 2009 Nov; 69(16):2227-43. PubMed ID: 19852526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
    Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
    Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors.
    Carminatti M; Tedesco-Silva H; Silva Fernandes NM; Sanders-Pinheiro H
    Nephrology (Carlton); 2019 Feb; 24(2):141-147. PubMed ID: 30159972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney transplantation in the older adult.
    Knoll GA
    Am J Kidney Dis; 2013 May; 61(5):790-7. PubMed ID: 23261121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
    Phanish MK; Hull RP; Andrews PA; Popoola J; Kingdon EJ; MacPhee IAM;
    BMC Nephrol; 2020 Mar; 21(1):92. PubMed ID: 32160893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
    Sawitzki B; Harden PN; Reinke P; Moreau A; Hutchinson JA; Game DS; Tang Q; Guinan EC; Battaglia M; Burlingham WJ; Roberts ISD; Streitz M; Josien R; Böger CA; Scottà C; Markmann JF; Hester JL; Juerchott K; Braudeau C; James B; Contreras-Ruiz L; van der Net JB; Bergler T; Caldara R; Petchey W; Edinger M; Dupas N; Kapinsky M; Mutzbauer I; Otto NM; Öllinger R; Hernandez-Fuentes MP; Issa F; Ahrens N; Meyenberg C; Karitzky S; Kunzendorf U; Knechtle SJ; Grinyó J; Morris PJ; Brent L; Bushell A; Turka LA; Bluestone JA; Lechler RI; Schlitt HJ; Cuturi MC; Schlickeiser S; Friend PJ; Miloud T; Scheffold A; Secchi A; Crisalli K; Kang SM; Hilton R; Banas B; Blancho G; Volk HD; Lombardi G; Wood KJ; Geissler EK
    Lancet; 2020 May; 395(10237):1627-1639. PubMed ID: 32446407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
    Karpe KM; Talaulikar GS; Walters GD
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006750. PubMed ID: 28730648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction Immunosuppression in High-risk Kidney Transplant Recipients.
    Buttigieg J; Julie BM; Sharma A; Halawa A
    Exp Clin Transplant; 2016 Aug; 14(4):367-76. PubMed ID: 27041548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, risk factors, and clinical impact of early post-transplant infection in older kidney transplant recipients: the Korean organ transplantation registry study.
    Kim JS; Jeong KH; Lee DW; Lee SY; Lee SH; Yang J; Ahn C; Hwang HS;
    BMC Geriatr; 2020 Dec; 20(1):519. PubMed ID: 33267808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized immunosuppression after kidney transplantation.
    Cheung CY; Tang SCW
    Nephrology (Carlton); 2022 Jun; 27(6):475-483. PubMed ID: 35238110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.
    Höcker B; Tönshoff B
    Paediatr Drugs; 2009; 11(6):381-96. PubMed ID: 19877724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Concepts in Managing Malignancy in Kidney Transplant Patients.
    Schreiber B; Abdelrahim M; Abudayyeh A; Murakami N
    Semin Nephrol; 2022 Jan; 42(1):63-75. PubMed ID: 35618396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
    Krisl A; Stampf S; Hauri D; Binet I; Mueller T; Sidler D; Hadaya K; Golshayan D; Pascual M; Koller M; Dickenmann M; The Swiss Transplant Cohort Study Stcs
    Swiss Med Wkly; 2020 Nov; 150():w20354. PubMed ID: 33277913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation in the elderly patient.
    Keith DS
    Clin Geriatr Med; 2013 Aug; 29(3):707-19. PubMed ID: 23849015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical management of chronic kidney disease in the renal transplant recipient.
    Ong SC; Gaston RS
    Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):587-93. PubMed ID: 26371526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients.
    Schaenman JM; Rossetti M; Sidwell T; Groysberg V; Sunga G; Korin Y; Liang E; Zhou X; Abdalla B; Lum E; Bunnapradist S; Pham T; Danovitch G; Reed EF
    Hum Immunol; 2018 Sep; 79(9):659-667. PubMed ID: 29913200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Therapeutic Dose Monitoring of Mycophenolic Acid on the Outcome of Live-Donor Kidney Transplant Recipients - A Prospective Controlled Study.
    Denewar AA; Mohamed EM; M Ismael MI; Ismail AM; Refaie AF
    Saudi J Kidney Dis Transpl; 2021; 32(1):128-136. PubMed ID: 34145122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.